Literature DB >> 26923604

Nutraceuticals in Acute and Prophylactic Treatment of Migraine.

Oved Daniel1, Alexander Mauskop2,3.   

Abstract

OPINION STATEMENT: People who suffer from headaches often prefer nutraceutical treatment over traditional pharmacological approaches, due to fear of possible side effects, drug dependence, or addiction. Since treatment with nutraceuticals does not require a doctor's prescription, many patients rely on their own judgment as to when and which one to take, often without consultation or guidance from their physician. Some physicians could provide information about potential efficacy and side effects of various products, but many are not familiar with the nutraceuticals. Widespread skepticism persists among doctors about the effectiveness of these treatments. This is largely due to the lack of rigorous clinical studies. However, even when incontrovertible scientific evidence exists, many physicians remain distrustful of the evidence. The following review summarizes randomized controlled trials of some of the most commonly used non-pharmacological treatments, including magnesium, coenzyme Q10, riboflavin (vitamin B2), petasites, and feverfew (Table 1).

Entities:  

Keywords:  Headache; Herbal preparation; Migraine; Minerals; Nutraceuticals; Vitamins

Year:  2016        PMID: 26923604     DOI: 10.1007/s11940-016-0398-1

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  42 in total

Review 1.  Migraine prophylactic drugs - something new under the sun?

Authors:  Svein I Bekkelund; Karl B Alstadhaug
Journal:  Expert Opin Investig Drugs       Date:  2011-08-06       Impact factor: 6.206

2.  Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract.

Authors:  Raymund Pothmann; Ulrich Danesch
Journal:  Headache       Date:  2005-03       Impact factor: 5.887

Review 3.  The Use of Complementary and Alternative Medicine in Patients with Migraine.

Authors:  Başak Karakurum Göksel
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

Review 4.  Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data.

Authors:  Mona Abdel-Tawab; Oliver Werz; Manfred Schubert-Zsilavecz
Journal:  Clin Pharmacokinet       Date:  2011-06       Impact factor: 6.447

5.  Migraine prevalence by age and sex in the United States: a life-span study.

Authors:  T W Victor; X Hu; J C Campbell; D C Buse; R B Lipton
Journal:  Cephalalgia       Date:  2010-03-12       Impact factor: 6.292

6.  Red blood cell magnesium levels in migraine patients.

Authors:  V Gallai; P Sarchielli; P Morucci; G Abbritti
Journal:  Cephalalgia       Date:  1993-04       Impact factor: 6.292

Review 7.  Integrated care for chronic migraine patients: epidemiology, burden, diagnosis and treatment options.

Authors:  Hans-Christoph Diener; Kasja Solbach; Dagny Holle; Charly Gaul
Journal:  Clin Med (Lond)       Date:  2015-08       Impact factor: 2.659

8.  A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacetum parthenium).

Authors:  A N Makheja; J M Bailey
Journal:  Prostaglandins Leukot Med       Date:  1982-06

9.  Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.

Authors:  Marcelo E Bigal; Daniel Serrano; Michael Reed; Richard B Lipton
Journal:  Neurology       Date:  2008-08-19       Impact factor: 9.910

10.  Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs.

Authors:  C Di Lorenzo; F Pierelli; G Coppola; G S Grieco; C Rengo; M Ciccolella; D Magis; M Bolla; C Casali; F M Santorelli; J Schoenen
Journal:  Neurology       Date:  2009-05-05       Impact factor: 9.910

View more
  10 in total

1.  The use of nutraceutics in children's and adolescent's headache.

Authors:  R Sangermani; A Boncimino
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

Review 2.  Usefulness of nutraceuticals in migraine prophylaxis.

Authors:  Florindo D'Onofrio; Simona Raimo; Daniele Spitaleri; Gerardo Casucci; Gennaro Bussone
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

Review 3.  Petasites for Migraine Prevention: New Data on Mode of Action, Pharmacology and Safety. A Narrative Review.

Authors:  Jürgen Borlak; Hans-Christoph Diener; Johanna Kleeberg-Hartmann; Karl Messlinger; Stephen Silberstein
Journal:  Front Neurol       Date:  2022-04-26       Impact factor: 4.086

Review 4.  Advances in paediatrics in 2019: current practices and challenges in allergy, endocrinology, gastroenterology, public health, neonatology, nutrition, nephrology, neurology, respiratory diseases and rheumatic diseases.

Authors:  Carlo Caffarelli; Francesca Santamaria; Virginia Mirra; Ermanno Bacchini; Angelica Santoro; Sergio Bernasconi; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2020-06-29       Impact factor: 2.638

Review 5.  The Effect of Magnesium Deficiency on Neurological Disorders: A Narrative Review Article.

Authors:  Wenwen Xue; Jing You; Yingchao Su; Qinglu Wang
Journal:  Iran J Public Health       Date:  2019-03       Impact factor: 1.429

Review 6.  The Use of Antioxidants in the Treatment of Migraine.

Authors:  Marta Goschorska; Izabela Gutowska; Irena Baranowska-Bosiacka; Katarzyna Barczak; Dariusz Chlubek
Journal:  Antioxidants (Basel)       Date:  2020-01-28

7.  Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis.

Authors:  Suhairul Sazali; Salziyan Badrin; Mohd Noor Norhayati; Nur Suhaila Idris
Journal:  BMJ Open       Date:  2021-01-05       Impact factor: 2.692

Review 8.  Non-Pharmacological Approaches to Headaches: Non-Invasive Neuromodulation, Nutraceuticals, and Behavioral Approaches.

Authors:  Licia Grazzi; Claudia Toppo; Domenico D'Amico; Matilde Leonardi; Paolo Martelletti; Alberto Raggi; Erika Guastafierro
Journal:  Int J Environ Res Public Health       Date:  2021-02-05       Impact factor: 3.390

Review 9.  Magnesium as an Important Factor in the Pathogenesis and Treatment of Migraine-From Theory to Practice.

Authors:  Izabela Domitrz; Joanna Cegielska
Journal:  Nutrients       Date:  2022-03-05       Impact factor: 5.717

10.  A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.

Authors:  Angèle Guilbot; Marie Bangratz; Samira Ait Abdellah; Christian Lucas
Journal:  BMC Complement Altern Med       Date:  2017-08-30       Impact factor: 3.659

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.